| 000 | 01910 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515014651.0 | ||
| 264 | 0 | _c20060626 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/j.bmcl.2006.01.055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThompson, Lorin A | |
| 245 | 0 | 0 |
_aSynthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cMay 2006 |
||
| 300 |
_a2357-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAmyloid Precursor Protein Secretases |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAspartic Acid Endopeptidases |
| 650 | 0 | 4 |
_aCaprolactam _xanalogs & derivatives |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEndopeptidases _xchemistry |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSuccinates _xchemistry |
| 700 | 1 | _aLiauw, Ann Y | |
| 700 | 1 | _aRamanjulu, Mercy M | |
| 700 | 1 | _aKasireddy-Polam, Padmaja | |
| 700 | 1 | _aMercer, Stephen E | |
| 700 | 1 | _aMaduskuie, Thomas P | |
| 700 | 1 | _aGlicksman, Marcie | |
| 700 | 1 | _aRoach, Arthur H | |
| 700 | 1 | _aMeredith, Jere E | |
| 700 | 1 | _aLiu, Rui-Qin | |
| 700 | 1 | _aCombs, Andrew P | |
| 700 | 1 | _aHigaki, Jeffrey N | |
| 700 | 1 | _aCordell, Barbara | |
| 700 | 1 | _aSeiffert, Dietmar | |
| 700 | 1 | _aZaczek, Robert C | |
| 700 | 1 | _aRobertson, David W | |
| 700 | 1 | _aOlson, Richard E | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 16 _gno. 9 _gp. 2357-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2006.01.055 _zAvailable from publisher's website |
| 999 |
_c16085485 _d16085485 |
||